Alexza Pharmaceuticals Inc
ALXA
ALXA was delisted on the 16th of June, 2016.
31 hedge funds and large institutions have $8.74M invested in Alexza Pharmaceuticals Inc in 2014 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 9 closing their positions.
1,893% more call options, than puts
Call options by funds: $1.48M | Put options by funds: $74K
13% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 8
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
18% less funds holding
Funds holding: 38 → 31 (-7)
43% less capital invested
Capital invested by funds: $15.2M → $8.74M (-$6.5M)
67% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$57.5K |
| 2 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
+$46.4K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$16.1K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$8.61K |
| 5 |
SA
SRH Advisors
Salina,
Kansas
|
+$7.14K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
-$563K |
| 2 |
FAM
Fortaleza Asset Management
Chicago,
Illinois
|
-$294K |
| 3 |
VM
VHCP Management
New York
|
-$166K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$117K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$111K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Citigroup
New York
| $1K | +$1.35K | +757 | +379% |
|
|
LTFS
27
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | +$1.61K | +900 | New |
|
28
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $3 | – | – | – |
|
|
FAM
29
Fortaleza Asset Management
Chicago,
Illinois
| – | -$294K | -126,095 | Closed |
|
|
VM
30
VHCP Management
New York
| – | -$166K | -71,212 | Closed |
|
|
BCM
31
Bridgeway Capital Management
Houston,
Texas
| – | -$117K | -50,000 | Closed |
|
|
BIT
32
BlackRock Institutional Trust
San Francisco,
California
| – | -$111K | -47,674 | Closed |
|
|
SIM
33
Spark Investment Management
New York
| – | -$80K | -33,800 | Closed |
|
|
LOCB
34
Lombard Odier & Cie (Bahamas)
Nassau,
Bahamas
| – | -$41K | -17,500 | Closed |
|
|
PP
35
PDT Partners
New York
| – | -$24K | -10,500 | Closed |
|
36
Dimensional Fund Advisors
Austin,
Texas
| – | -$6K | -2,650 | Closed |
|
|
TRCT
37
Tower Research Capital (TRC)
New York
| – | -$1.03K | -578 | -66% |
|
ALXA Hedge Fund Activity: Q4 2014 in Review
31 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Alexza Pharmaceuticals Inc (ALXA) for Q4 2014, worth a combined $8.74M — down 43% from $15.2M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of ALXA and 3 opened new positions — a net loss of 6 holders — while 8 trimmed existing stakes and 9 added.
The largest buyer was Geode Capital Management, adding an estimated $57.5K. The largest seller was C WorldWide Group, cutting an estimated $563K.
- 31 institutional investors held Alexza Pharmaceuticals Inc (ALXA) as of Q4 2014, down from 38 in Q3 2014.
- Funds reported $8.74M of Alexza Pharmaceuticals Inc stock for Q4 2014, down 43% quarter-over-quarter.
- 3 funds opened new Alexza Pharmaceuticals Inc positions in Q4 2014 and 9 closed out, a net change of -6 holders.
- The largest Alexza Pharmaceuticals Inc buyer in Q4 2014 was Geode Capital Management, an estimated $57.5K added.
- The largest Alexza Pharmaceuticals Inc seller in Q4 2014 was C WorldWide Group, an estimated $563K sold.
Based on aggregated 13F filings for Q4 2014.